Lu Bian Selected Research

Hexestrol

1/2022

ITGB3BP is a potential biomarker associated with poor prognosis of glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lu Bian Research Topics

Disease

3	Glioma (Gliomas) 01/2022 - 01/2021
2	Infections 10/2019 - 09/2019
1	Epidermolysis Bullosa Pruriginosa 01/2023
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2020

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 10/2019 - 09/2019
1	dupilumabIBA 01/2023
1	HexestrolIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	CanavanineIBA 01/2021
1	Doxazosin (Cardura)FDA LinkGeneric 01/2021
1	quinostatinIBA 01/2021
1	chrysinIBA 01/2021
1	jasmonic acid (jasmonate)IBA 10/2019
1	methyl jasmonateIBA 09/2019

Therapy/Procedure

1	Catheters 05/2020
1	Thrombectomy 05/2020